Cadrenal Therapeutics, Inc. (CVKD) Operating cash flow 2023–2025
Cadrenal Therapeutics, Inc. (CVKD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.6MFY2025 · since FY2023: -$3.5M → -$12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.6M | -71.3% |
| FY2024 | -$7.4M | -108.4% |
| FY2023 | -$3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice